Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jeffrey

Showing results (231-240 of 302) with videos related to

Pageof 31
Sort By:
Oncotarget|January 11, 2015
Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platformEvelyn Kidess, Kyra Heirich, Matthew Wiggin, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chainA J Cocuzza, D R Chidester, B C Cordova, et al.
Oecologia|April 12, 2023
Multiple and contrasting pressures determine intraspecific phytochemical variation in a tropical shrubAndrea E Glassmire, Walter P Carson, Angela M Smilanich, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 28, 2012
Loss of equilibrative nucleoside transporter 1 in mice leads to progressive ectopic mineralization of spinal tissues resembling diffuse idiopathic skeletal hyperostosis in humansSumeeta Warraich, Derek B J Bone, Diana Quinonez, et al.
Molecular Cancer Therapeutics|February 28, 2018
Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug ActivationJing-Hung Wang, Alexis V Forterre, Jinjing Zhao, et al.
Nature Methods|August 25, 2005
A streamlined platform for high-content functional proteomics of primary human specimensNadim Jessani, Sherry Niessen, BinQing Q Wei, et al.
Cancer Research|June 28, 2014
High-throughput time-resolved FRET reveals Akt/PKB activation as a poor prognostic marker in breast cancerSelvaraju Veeriah, Pierre Leboucher, Julien de Naurois, et al.
BMC Genomics|September 13, 2006
Discovery and validation of breast cancer subtypesAmy V Kapp, Stefanie S Jeffrey, Anita Langerød, et al.
Clinical & Experimental Metastasis|April 27, 2020
Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancerAryana M Razmara, Elodie Sollier, Grace N Kisirkoi, et al.
Molecular Systems Biology|July 21, 2011
A pharmacogenomic method for individualized prediction of drug sensitivityAdam L Cohen, Raffaella Soldi, Haiyu Zhang, et al.
Pageof 31

Showing results (231-240 of 302) with videos related to

Sort By:
Pageof 31
Oncotarget|January 11, 2015
Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platformEvelyn Kidess, Kyra Heirich, Matthew Wiggin, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chainA J Cocuzza, D R Chidester, B C Cordova, et al.
Oecologia|April 12, 2023
Multiple and contrasting pressures determine intraspecific phytochemical variation in a tropical shrubAndrea E Glassmire, Walter P Carson, Angela M Smilanich, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 28, 2012
Loss of equilibrative nucleoside transporter 1 in mice leads to progressive ectopic mineralization of spinal tissues resembling diffuse idiopathic skeletal hyperostosis in humansSumeeta Warraich, Derek B J Bone, Diana Quinonez, et al.
Molecular Cancer Therapeutics|February 28, 2018
Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug ActivationJing-Hung Wang, Alexis V Forterre, Jinjing Zhao, et al.
Nature Methods|August 25, 2005
A streamlined platform for high-content functional proteomics of primary human specimensNadim Jessani, Sherry Niessen, BinQing Q Wei, et al.
Cancer Research|June 28, 2014
High-throughput time-resolved FRET reveals Akt/PKB activation as a poor prognostic marker in breast cancerSelvaraju Veeriah, Pierre Leboucher, Julien de Naurois, et al.
BMC Genomics|September 13, 2006
Discovery and validation of breast cancer subtypesAmy V Kapp, Stefanie S Jeffrey, Anita Langerød, et al.
Clinical & Experimental Metastasis|April 27, 2020
Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancerAryana M Razmara, Elodie Sollier, Grace N Kisirkoi, et al.
Molecular Systems Biology|July 21, 2011
A pharmacogenomic method for individualized prediction of drug sensitivityAdam L Cohen, Raffaella Soldi, Haiyu Zhang, et al.
Pageof 31